Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Aass

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The American Journal of Cardiology|March 11, 1999
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyP Aukrust, T Ueland, E Lien, et al.
Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.
European Journal of Clinical Investigation|May 31, 2001
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failureH G Eiken, E Øie, J K Damås, et al.
Cardiovascular Research|September 7, 2000
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failureJ K Damås, H G Eiken, E Oie, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The American Journal of Cardiology|March 11, 1999
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyP Aukrust, T Ueland, E Lien, et al.
Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.
European Journal of Clinical Investigation|May 31, 2001
Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failureH G Eiken, E Øie, J K Damås, et al.
Cardiovascular Research|September 7, 2000
Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failureJ K Damås, H G Eiken, E Oie, et al.
Pageof 5